GlassScriptPhysician profile
Vivekanand Manocha
NPI 1992727200
$22,039.58
in general payments reported to CMS, 2019-2025
27 companies · $5,357 in 2025
The $5,357 reported for 2025 was more than what 91% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,918 · 2020: $1,800 · 2021: $2,492 · 2022: $3,727 · 2023: $2,229 · 2024: $2,516 · 2025: $5,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,346 · Travel and Lodging: $1,656 · Consulting Fee: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,346.13 |
| Travel and Lodging | $1,655.94 |
| Consulting Fee | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,522.12 | 2019-2025 | Proclaim, Eterna |
| Vertos Medical, INC. | $2,766.86 | 2020-2024 | Mild Device Kit |
| Curonix LLC | $2,200.28 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $2,004.04 | 2019-2025 | Artisan, General - Therapies, Clinical Trial Product |
| Spinal Simplicity, LLC | $1,570.96 | 2021-2022 | |
| Vertiflex, INC. | $1,544.84 | 2019 | |
| Biotronik Nro, INC. | $1,182.60 | 2025 | Prospera |
| Nevro Corp. | $965.75 | 2019-2022 | |
| Globus Medical, INC. | $832.32 | 2025 | Vyrsa V1, Senza, Omnia |
| Stimwave Technologies Incorporated | $773.56 | 2019-2022 | |
| Stryker Corporation | $536.53 | 2024-2025 | Mild Device Kit |
| Medtronic, INC. | $392.27 | 2021-2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Saluda Medical Americas, INC. | $351.28 | 2024-2025 | Evoke |
| Nalu Medical, INC. | $340.64 | 2021-2023 | Nalu Neurostimulation System |
| Medtronic USA, INC. | $232.30 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $178.95 | 2021-2023 | Painteq |
| Avanos Medical | $147.64 | 2022 | |
| Spr Therapeutics, INC | $135.71 | 2025 | Sprint Pns System |
| Amgen INC. | $114.65 | 2019 | |
| Pfizer INC. | $82.78 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $33.31 | 2019 | |
| Assertio Therapeutics, INC. | $29.92 | 2019 | |
| Spinefrontier, INC. | $27.24 | 2020 | |
| Bioventus LLC | $24.94 | 2024 | Durolane |
| Vertex Pharmaceuticals Incorporated | $20.90 | 2025 | |
| Depuy Synthes Sales INC. | $13.61 | 2025 | Monovisc, Orthovisc |
| Lilly USA, LLC | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivekanand Manocha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.